Using computer modeling to find new LRRK2 inhibitors for parkinson’s disease
Abstract Parkinson’s disease (PD) is a complex neurodegenerative disorder that affects multiple neurotransmitters, and its exact cause is still unknown. Developing new drugs for PD is a lengthy and expensive process, making it difficult to find new treatments. This study aims to create a detailed da...
Saved in:
Main Authors: | María C. García, Sebastián A. Cuesta, José R. Mora, Jose L. Paz, Yovani Marrero-Ponce, Frank Alexis, Edgar A. Márquez |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-86926-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Altered resting-state cerebral blood flow and its relationship with molecular architecture in tremor dominant Parkinson’s disease
by: Shangpei Wang, et al.
Published: (2025-03-01) -
Genetic screening of South African families with Parkinson’s disease
by: S Bardien, et al.
Published: (2024-02-01) -
Telomerase inhibiting phytochemicals derived from Blumea eriantha for cancer treatment: A comprehensive computational analysis
by: Rahil Ummar Faruk Abbu, et al.
Published: (2025-02-01) -
Deciphering CSU pathogenesis: Network toxicologyand molecular dynamics of DOTP exposure
by: Fang Cao, et al.
Published: (2025-02-01) -
DockCADD: A streamlined in silico pipeline for the identification of potent ribosomal S6 Kinase 2 (RSK2) inhibitors
by: El Mehdi Karim, et al.
Published: (2025-03-01)